e-learning
resources
Munich 2014
Tuesday, 09.09.2014
Experimental models in acute lung injury
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Acid sphingomyelinase mediates IL-6 release in experimental LPS-induced lung injury
R. Pandolfi, B. Barreira, A. Martinez-Ramas, E. Moreno, V. Lara-Acedo, D. Morales-Cano, V. Chamorro, A. Cogolludo, F. Pérez-Vizcaíno F, L. Moreno (Madrid, Spain)
Source:
International Congress 2014 – Experimental models in acute lung injury
Session:
Experimental models in acute lung injury
Session type:
Thematic Poster Session
Number:
3937
Disease area:
Respiratory critical care
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
R. Pandolfi, B. Barreira, A. Martinez-Ramas, E. Moreno, V. Lara-Acedo, D. Morales-Cano, V. Chamorro, A. Cogolludo, F. Pérez-Vizcaíno F, L. Moreno (Madrid, Spain). Acid sphingomyelinase mediates IL-6 release in experimental LPS-induced lung injury. Eur Respir J 2014; 44: Suppl. 58, 3937
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
The impact of anti-IgE treatment on the airway microbiome in asthma.
Indications and pitfalls of high-flow nasal cannula (HFNC) outside the intensive care unit
Related content which might interest you:
Neutrophil elastase inhibitor sivelestat ameliorates gefitinib-induced acute pneumonitis in mice
Source: International Congress 2014 – Experimental models in acute lung injury
Year: 2014
Preventive and therapeutic treatment with a7 nicotinic receptor agonist reduced lung inflammation and collagen deposition in mice with acute lung injury
Source: International Congress 2014 – Experimental models in acute lung injury
Year: 2014
Instilled surfactant stimulates the expression of surfactant protein A, ameliorating the inhalation injury in rats
Source: International Congress 2014 – Experimental models in acute lung injury
Year: 2014
Microparticles as biomarkers of lung injury in human broncho-alveolar lavage fluid
Source: International Congress 2014 – Translational studies in COPD
Year: 2014
Sirolimus induced diffuse alveolar hemorrhage: A case report
Source: International Congress 2016 – Orphan diseases II
Year: 2016
Cytologicalfeaturesof bronchoalveolar lavage in different variants of exogenous allergic alveolitis
Source: International Congress 2014 – ILDs 5
Year: 2014
Viral mimetic Poly(I:C) exacerbates cigarette smoke-induced pulmonary inflammation by facilitating the release of neutrophil-derived elastase
Source: International Congress 2014 – Mechanisms of COPD and inhalation injury
Year: 2014
Investigation of mitochondria homeostasis and mitophagy in bronchoalveolar lavage fluid (BALF) cells in pulmonary fibrosis
Source: International Congress 2015 – IPF pathogenesis
Year: 2015
Relation of sputum and BAL neutrophils to the development of Chronic Lung Allograft Dysfunction after lung transplantation
Source: International Congress 2017 – The ongoing struggle: insights into chronic lung allograft dysfunction (CLAD)
Year: 2017
Dexamethasone inhibits secretory and cytosolic phospholipases A2 in alveolar macrophages in acute lung injury
Source: Annual Congress 2013 –Macrophages, mononuclear cells and viral infection
Year: 2013
Involvement of the JAK-STAT3 pathway in a lipopolysaccharide-induced rat model of airway inflammation
Source: Annual Congress 2013 –Novel drugs and biomarkers in respiratory medicine
Year: 2013
Autophagy is not impaired in BALF alveolar macrophages in IPF: Preliminary results
Source: International Congress 2014 – ILDs 3
Year: 2014
Impact of Wnt ligand secretion on cellular phenotypes in pulmonary fibrosis
Source: International Congress 2014 – New and old players in fibrotic lung disease
Year: 2014
Macrophage polarization in interstitial lung diseases
Source: International Congress 2014 – ILDs 2
Year: 2014
Rapid activation of pulmonary endothelial cells during high stretch ventilation
in vivo
Source: International Congress 2014 – Acute lung injury: hitting the barriers
Year: 2014
Effects of cyclosporin H on airway inflammatory responses induced by mitochondrial damage-associated molecular patterns
Source: International Congress 2014 – Animal models in respiratory drug development
Year: 2014
Assessment of ATP degradation in bronchoalveolar lavage fluid
Source: Annual Congress 2013 –Biomarkers in asthma and COPD
Year: 2013
Extracellular ATP is a danger signal activating P2X7 Receptor in a LPS mediated inflammation (ARDS)
Source: International Congress 2015 – Novel insights into the pathobiology of acute lung injury
Year: 2015
Chrysin reduces the degree of lung injure which induced by lipopolysaccharides (LPS): Possible involvement of oxidative stress and the NF-κB pathway
Source: International Congress 2014 – Experimental models in acute lung injury
Year: 2014
The role of ATP and purinergic-receptor- signalling in the pathogenesis of ALI/ARDS
Source: Annual Congress 2013 –Cell signalling and inflammation: what's new in 2013?
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept